Form D · Other Health Care

Goodwin Biotechnology, Inc

Plantation, FL · CIK 0001774572

Offering snapshot reported Jan 27, 2026 · SEC filing

Reported sold
$2M
Offering amount: $4M
Investors reported
2
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Dec 5, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 27, 2026Initial$2,000,000No comparison2SEC filing
Nov 12, 2024Initial$3,000,000No comparison1SEC filing
Oct 2, 2023Initial$5,000,002No comparison3SEC filing
Apr 30, 2019Initial$20,725,000No comparison5SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-571232

Source: Form D, filed Jan 27, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sunil K. Agarwal Executive
Soo Young S. Lee Executive
Jerry Liao Director
Cesar Menezes Director
Divya Menezes Director
Maria Emila Menezes Director
Kent Payne Director
Karl Pinto Director, Executive
Brandon Price Director
Nikhil Puri Director
Darrin Schellin Director, Executive
Steven Vorgity Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1850 Nw 69 Th Avenue, Suite 4
Plantation, FL, 33313